Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Code

Type your Poster Code, then hit apply

Showing 1,267 results.

Thumbnail for Asciminib in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase (Ph+ CML-CP): A Retrospective Chart Review Study in the US

CML - 692

Asciminib in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase (Ph+ CML-CP): A Retrospective Chart Review Study in the US

Ehab L Atallah

Poster Presenter: Ehab L Atallah

Thumbnail for Adherence of Asciminib vs ATP-Competitive Tyrosine Kinase Inhibitors (TKIs) in Second Line (2L) for Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

CML - 694

Adherence of Asciminib vs ATP-Competitive Tyrosine Kinase Inhibitors (TKIs) in Second Line (2L) for Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Akriti G Jain

Poster Presenter: Akriti G Jain

Previous 1...61 62 63 64 65 66 67...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Co-Existing Myeloid Mutations at Diagnosis Are Associated With Increased Tyrosine Kinase Inhibitor Utilization in Chronic Phase CML

CML - 709

Co-Existing Myeloid Mutations at Diagnosis Are Associated With Increased Tyrosine Kinase Inhibitor Utilization in Chronic Phase CML

Umar Iqbal

Poster Presenter: Umar Iqbal

Thumbnail for Blastic Crisis of CML in a Patient With Underlying CLL.

CML - 713

Blastic Crisis of CML in a Patient With Underlying CLL.

Ricardo Romano

Poster Presenter: Ricardo Romano

Thumbnail for Efficacy of Olverembatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia (CP-CML) With Prior Resistance to Ponatinib or Asciminib and ASXL1 Mutations

CML - 731

Efficacy of Olverembatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia (CP-CML) With Prior Resistance to Ponatinib or Asciminib and ASXL1 Mutations

Elias Jabbour

Poster Presenter: Elias Jabbour

Thumbnail for Comparison of the Incidence of Cardiovascular Adverse Events in Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors With Representatives of the General Population

CML - 797

Comparison of the Incidence of Cardiovascular Adverse Events in Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors With Representatives of the General Population

Nadezhda Shnalieva

Poster Presenter: Nadezhda Shnalieva

Thumbnail for Mutation analysis of ABL kinase domain in Tunisian CML patients treated with tyrosine kinase inhibitors

CML - 899

Mutation analysis of ABL kinase domain in Tunisian CML patients treated with tyrosine kinase inhibitors

Rim Frikha

Poster Presenter: Rim Frikha

Thumbnail for Asciminib vs Dasatinib/Nilotinib as First-Line Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: A Propensity Score-Matched Analysis of Disease Progression and Safety Outcomes

CML - 913

Asciminib vs Dasatinib/Nilotinib as First-Line Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: A Propensity Score-Matched Analysis of Disease Progression and Safety Outcomes

Ali Turunc

Poster Presenter: Ali Turunc

Thumbnail for Asciminib (ASC) in Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Interim Analysis (IA) Efficacy and Safety Results of the Phase 2 ASC2ESCALATE Trial in the Cohort of Newly Diagnosed Patients

CML - 918

Asciminib (ASC) in Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Interim Analysis (IA) Efficacy and Safety Results of the Phase 2 ASC2ESCALATE Trial in the Cohort of Newly Diagnosed Patients

Moshe Levy

Poster Presenter: Moshe Levy

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.